JSLCX | PACAX | JSLCX / PACAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 19 years | 31 years | - |
Gain YTD | 6.267 | 10.123 | 62% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.65B | 576M | 287% |
Annual Yield % from dividends | 3.69 | 2.18 | 169% |
Returns for 1 year | 11.81 | 16.76 | 70% |
Returns for 3 years | -4.11 | -2.74 | 150% |
Returns for 5 years | 7.68 | 11.40 | 67% |
Returns for 10 years | 14.82 | 15.39 | 96% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GPGCX | 16.98 | 0.11 | +0.65% |
Grandeur Peak Global Contrarian Instl | |||
JHLVX | 62.38 | N/A | N/A |
JHancock Fundamental Large Cap Core C | |||
FIUSX | 38.16 | N/A | N/A |
Delaware Opportunity A | |||
NSFEX | 11.43 | -0.04 | -0.35% |
Natixis Target Retirement 2025 N | |||
ETNHX | 34.80 | -0.82 | -2.30% |
Eventide Healthcare & Life Sciences N |